(0)

DIA会员及用户请点击登录

登录

忘记用户 ID？ or 忘记密码？

Not a Member?

创建账户并加入。

Omni Shoreham Hotel

2019 年 01 月 27 日 9:00 上午 - 2019 年 01 月 27 日 12:30 下午

2500 Calvert Street NW, , Washington, DC 20008 , USA

Short Course 3: Reference Safety Information

概览

SUNDAY, JANUARY 27 | 9:00AM-12:30PM

This half-day short course will be conducted in two parts. The first part will focus on the basic aspects of the EU regulation and EU guidances (including Q&A documents) that govern the content, placement, use, and management of the Reference Safety Information as used in assessing expectedness of “suspected” serious adverse reactions (SARs) from clinical trials. The second part will focus on the practical aspects of implementing the regulations and guidances, including a review of acceptable and non-acceptable examples of the RSI and examples of regulatory agency inspection findings related to the RSI.

*Short Courses are not included in the meeting registration and require a separate fee.

Return to Pharmacovigilance and Risk Management Strategies.

学习目标

At the conclusion of this short course, participants should be able to:
  • Describe the requirements for the use and management of the RSI in clinical trials
  • Understand how the requirements for RSI as described in the CTFG Q&A document are enforced by regulatory agencies
  • Be able to develop compliant RSI processes and documentation

    获得信息并保持参与

    不要错失任何机会——请加入我们的邮件列表，了解DIA的观点和事件。